20 August 2024
Latham Advises Phathom Pharmaceuticals on US$130 Million Offering of Common Stock and Pre-Funded Warrants
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Matt Bush Lead | Latham & Watkins LLP | Partner | corporate | San Diego |
| Cheston Larson Lead | Latham & Watkins LLP | Partner | corporate | San Diego |
| Anthony Gostanian | Latham & Watkins LLP | Counsel | corporate | Not stated |
| Rachel Staub | Latham & Watkins LLP | Associate | corporate | Not stated |
| Samantha Wang | Latham & Watkins LLP | Associate | corporate | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 130m (US$130 million)
- What the figure measures
- Issue size
- Client
- Phathom PharmaceuticalsIssuer
- Counterparties
- Not stated